Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF

PJP

US46137V6627

Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals Etf Reports Earnings Results for the Full Year Ended April 30, 2020

July 08, 2020 at 01:43 pm EDT

Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF announced earnings results for the full year ended April 30, 2020. For the full year, the company announced total revenue was USD 5.435 million. Net loss was USD 3.199 million.

Latest news about Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF

Invesco Exchange-Traded Fund Trust - Invesco Pharmaceuticals ETF Reports Earnings Results for the Half Year Ended October 31, 2023	Jan. 03	CI
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF Reports Earnings Results for the Full Year Ended April 30, 2023	23-07-06	CI
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF Reports Earnings Results for the Half Year Ended October 31, 2022	23-01-05	CI
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals Etf Reports Earnings Results for the Full Year Ended April 30, 2021	21-07-08	CI
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals Etf Reports Earnings Results for the Full Year Ended April 30, 2020	20-07-08	CI
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF Reports Earnings Results for the Half Year Ended October 31, 2019	20-01-03	CI
Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF Reports Earnings Results for the Half Year Ended October 31, 2018	19-01-04	CI

Chart Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF

Duration

Period

Chart Invesco Exchange-Traded Fund Trust - Invesco Dynamic Pharmaceuticals ETF

More charts

Company Profile

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. The Index consists of stocks of 30 United States pharmaceutical companies. These are companies that are principally engaged in the research, development, manufacture, sale or distribution of pharmaceuticals and drugs of all types. The Fund normally invests at least 90% of its total assets in common stocks that consists of the Index. The Fund's investment advisor is Invesco PowerShares Capital Management LLC.

Sector

Investment Trusts

More about the company

Sector Investment Trusts

	1st Jan change	Capi.
SCOTTISH MORTGAGE INVESTMENT TRUST PLC	+9.46%	15.41B
F&C INVESTMENT TRUST PLC	+8.11%	6.48B
POLAR CAPITAL TECHNOLOGY TRUST PLC	+16.18%	4.53B
ALLIANCE TRUST PLC	+13.13%	4.44B
GREENCOAT UK WIND PLC	-5.21%	4.19B
RIT CAPITAL PARTNERS PLC	+4.57%	3.56B
JPMORGAN GLOBAL GROWTH & INCOME PLC	+12.33%	3.34B
THE MONKS INVESTMENT TRUST PLC	+10.92%	3.16B
HGCAPITAL TRUST PLC	+13.69%	2.82B

Investment Trusts